CY1111607T1 - Ενωσεις 1-φαινυλο-2-διμεθυλαμινομεθυλο-κυκλοεξανιου για τη θεραπεια καταθλιπτικων συμπτωματικων, πονου και ακρατειας ουρων - Google Patents

Ενωσεις 1-φαινυλο-2-διμεθυλαμινομεθυλο-κυκλοεξανιου για τη θεραπεια καταθλιπτικων συμπτωματικων, πονου και ακρατειας ουρων

Info

Publication number
CY1111607T1
CY1111607T1 CY20111100144T CY111100144T CY1111607T1 CY 1111607 T1 CY1111607 T1 CY 1111607T1 CY 20111100144 T CY20111100144 T CY 20111100144T CY 111100144 T CY111100144 T CY 111100144T CY 1111607 T1 CY1111607 T1 CY 1111607T1
Authority
CY
Cyprus
Prior art keywords
treatment
painylo
methymo
depressional
cycloexane
Prior art date
Application number
CY20111100144T
Other languages
English (en)
Inventor
Elmar Friderichs
Wolfgang Strassburger
Ulrich Jahnel
Dr Oswald Zimmer
Dr Derek Saunders
Dr Werner Englberger
Dr Hagen-Heinrich Hennies
Dr Helmut Buschmann
Jörg Holenz
Original Assignee
Grünenthal GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Grünenthal GmbH filed Critical Grünenthal GmbH
Publication of CY1111607T1 publication Critical patent/CY1111607T1/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/10—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/48—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/46—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/64—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
    • C07C291/02—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds
    • C07C291/04—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00 containing nitrogen-oxide bonds containing amino-oxide bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C305/00—Esters of sulfuric acids
    • C07C305/22—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings
    • C07C305/24—Esters of sulfuric acids having oxygen atoms of sulfate groups bound to carbon atoms of six-membered aromatic rings of non-condensed six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Abstract

Η εφεύρεση αφορά μεταβολίτες [2-(3-μεθοξυφαινυλο)-κυκλοεξυλομεθυλο]-διμεθυλαμίνης σαν ελεύθερες βάσεις και/ή στη μορφή φυσιολογικά υποφερτών αλάτων, αντίστοιχα φάρμακα καθώς και την χρησιμοποίηση [2-(3-μεθοξυφαινυλο)-κυκλοεξυλομεθυλο]-διμεθυλαμίνης και των μεταβολιτών της για την παρασκευή ενός φαρμάκου για τη θεραπεία καταθλίψεων και μεθόδους για τη θεραπεία καταθλίψεων.
CY20111100144T 2002-07-19 2011-02-08 Ενωσεις 1-φαινυλο-2-διμεθυλαμινομεθυλο-κυκλοεξανιου για τη θεραπεια καταθλιπτικων συμπτωματικων, πονου και ακρατειας ουρων CY1111607T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10233048A DE10233048A1 (de) 2002-07-19 2002-07-19 Verwendung von 1-Phenyl-3dimethylamino-propanverbindungen zur Therapie von depressiven Symptomatiken
EP03765006A EP1530462B1 (de) 2002-07-19 2003-07-16 1-phenyl-2-dimethylaminomethylcyclohexanverbindungen zur therapie von depressiven symptomatiken, schmerz und inkontinenz

Publications (1)

Publication Number Publication Date
CY1111607T1 true CY1111607T1 (el) 2015-10-07

Family

ID=29796483

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20111100144T CY1111607T1 (el) 2002-07-19 2011-02-08 Ενωσεις 1-φαινυλο-2-διμεθυλαμινομεθυλο-κυκλοεξανιου για τη θεραπεια καταθλιπτικων συμπτωματικων, πονου και ακρατειας ουρων

Country Status (26)

Country Link
EP (1) EP1530462B1 (el)
JP (1) JP4616644B2 (el)
KR (1) KR101056343B1 (el)
CN (1) CN1697651B (el)
AR (1) AR040574A1 (el)
AT (1) ATE491442T1 (el)
AU (1) AU2003263179B2 (el)
BR (1) BR0312854A (el)
CA (1) CA2492876C (el)
CO (1) CO5680411A2 (el)
CY (1) CY1111607T1 (el)
DE (2) DE10233048A1 (el)
DK (1) DK1530462T3 (el)
EC (1) ECSP055583A (el)
ES (1) ES2357947T3 (el)
HK (1) HK1075843A1 (el)
IL (2) IL166363A (el)
MX (1) MXPA05000791A (el)
NO (1) NO333812B1 (el)
PE (1) PE20050126A1 (el)
PL (1) PL214703B1 (el)
PT (1) PT1530462E (el)
RU (1) RU2387446C2 (el)
SI (1) SI1530462T1 (el)
WO (1) WO2004009067A1 (el)
ZA (1) ZA200501428B (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1562567T (pt) * 2002-11-22 2017-08-24 Gruenenthal Gmbh Combinação de analgésicos selecionados e inibidores da cox-ii
DE10356362A1 (de) 2003-11-28 2005-06-23 Grünenthal GmbH Verwendung von 1-Phenyl-3-dimethylamino-propanverbindungen zur Therapie von Angststörungen
AU2005290980A1 (en) * 2004-10-01 2006-04-13 Neurocure Ltd Use of pharmaceutical compositions of lofepramine for the treatment of ADHD, CFS, FM and depression
EP2336103A3 (de) * 2005-07-22 2011-07-20 Grünenthal GmbH HCL-Polymorphe von 3-[2-(Dimethylamino)methyl-(cyclohex-1-yl)]phenol
DE102005034973A1 (de) * 2005-07-22 2007-02-15 Grünenthal GmbH Salz von Dimethylaminomethyl-phenyl-cyclohexan und dessen kristalline Formen
NZ580429A (en) 2007-05-31 2012-04-27 Sepracor Inc Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
EP2085081A1 (de) * 2008-02-04 2009-08-05 Grünenthal GmbH 3-(2-Dimethylaminomethyl-cyclohexyl)-phenol gegen polyneuropathischen Schmerz
WO2011147576A1 (en) * 2010-05-28 2011-12-01 Grünenthal GmbH Process for the preparation of substituted 1-aminomethyl-2-phenyl-cyclohexane compounds
WO2012100423A1 (en) * 2011-01-27 2012-08-02 Eli Lilly And Company Analgesic compounds, methods, and formulations
EP2617706B1 (en) 2011-07-29 2017-09-06 Anhui New Star Pharmaceutical Development Co., Ltd Novel intermediate used for preparing tapentadol or analogues thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19525137C2 (de) * 1995-07-11 2003-02-27 Gruenenthal Gmbh 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbin -dungen als Zwischenprodukte zur Herstellung pharmazeutischer Wirkstoffe
PE20010623A1 (es) * 1999-10-05 2001-07-07 Gruenenthal Chemie Uso de (+)-tramadol y/o o-demetiltramadol para tratamiento de urgencia urinaria incrementada y/o incontinencia urinaria
JP2001233762A (ja) * 2000-02-21 2001-08-28 Gruenenthal Gmbh Ｏ−デスメチル−ｎ−モノ−デスメチル−トラマドールの使用方法
DE10059411A1 (de) * 2000-11-30 2002-06-13 Gruenenthal Gmbh Verwendung von 6-Dimethylaminomethyl-1-phenyl-cyclohexanverbindungen zur Therapie der Harninkontinenz

Also Published As

Publication number Publication date
CA2492876C (en) 2011-06-14
CA2492876A1 (en) 2004-01-29
RU2387446C2 (ru) 2010-04-27
JP4616644B2 (ja) 2011-01-19
DE50313329D1 (de) 2011-01-27
HK1075843A1 (en) 2005-12-30
DE10233048A1 (de) 2004-01-29
CN1697651B (zh) 2011-09-21
PL214703B1 (pl) 2013-09-30
BR0312854A (pt) 2005-04-19
ZA200501428B (en) 2006-09-27
ATE491442T1 (de) 2011-01-15
IL209789A0 (en) 2011-02-28
ES2357947T3 (es) 2011-05-04
PT1530462E (pt) 2011-02-22
AR040574A1 (es) 2005-04-13
AU2003263179B2 (en) 2009-10-22
KR20050019909A (ko) 2005-03-03
IL166363A0 (en) 2006-01-16
CN1697651A (zh) 2005-11-16
WO2004009067A1 (de) 2004-01-29
CO5680411A2 (es) 2006-09-29
KR101056343B1 (ko) 2011-08-12
AU2003263179A1 (en) 2004-02-09
NO333812B1 (no) 2013-09-23
RU2005104821A (ru) 2006-01-20
ECSP055583A (es) 2005-04-18
EP1530462A1 (de) 2005-05-18
SI1530462T1 (sl) 2011-03-31
DK1530462T3 (da) 2011-02-14
PL375629A1 (en) 2005-12-12
IL166363A (en) 2012-05-31
NO20050861L (no) 2005-02-17
JP2006511453A (ja) 2006-04-06
MXPA05000791A (es) 2005-10-19
PE20050126A1 (es) 2005-04-19
EP1530462B1 (de) 2010-12-15

Similar Documents

Publication Publication Date Title
CY1111607T1 (el) Ενωσεις 1-φαινυλο-2-διμεθυλαμινομεθυλο-κυκλοεξανιου για τη θεραπεια καταθλιπτικων συμπτωματικων, πονου και ακρατειας ουρων
CY1117656T1 (el) Επιλογες θεραπειας για τη νοσο του fabry
ATE420632T1 (de) Titrationsdosierschema für kontrolliert freigesetztes tramadol
BR0308188A (pt) Forma de administração a ser aplicada oralmente, para substâncias ativas básicas de difìcil solubilidade
CY1108436T1 (el) Χορηγηση καψαϊκινοειδων
CY1109880T1 (el) ΑΝΤΑΓΩΝΙΣΤΗΣ CaSR
ATE486860T1 (de) Phenothiazin-derivat zur wundheilung
BRPI0513819A (pt) inibidores de hsp90
RS51213B (sr) Farmaceutski vaginalni gel koji sadrži tenofovir
BRPI0713425A2 (pt) composto, composição farmacêutica, método para tratar uma doença, uso de um composto, e processos para a preparação de um composto, e para a fabricação de um composto
BRPI0415288A (pt) composto, composição farmacêutica, método para tratar ou prevenir doenças, e, método para preparar o composto
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
CY1106386T1 (el) Υποκατεστημενα παραγωγα 3-πυρρολιδιν-ινδολης
GB0211649D0 (en) Organic compounds
AR034213A1 (es) Composiciones de medicamentos sobre la base de agentes anticolinergicos e inhibidores de pde-iv
ATE308341T1 (de) Pharmazeutische formulierungen
SE0401342D0 (sv) Therapeutic compounds
AR032293A1 (es) Estuche farmaceutico
CY1108377T1 (el) Χρηση ενωσεων 1-φαινυλο-3-διμεθυλαμινο-προπανιου για τη θεραπεια της ακρατειας ουρων
NO20063308L (no) Kombinasjon av flupirtin og tramadol
ATE505187T1 (de) Pharmazeutische zusammensetzung mit verzögerter freisetzung aus tolterodin
CY1105317T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
CY1105142T1 (el) Χρηση υποκατεστημενων ενωσεων 6-διμεθυλαμινομεθυλο-1-φαινυλο-κυκλοεξανιου για τη θepαπεια της ακρατειας ουρων
DE60317993D1 (de) Pharmazeutische Zubereitung mit verzögerter Freisetzung zur oralen Wirkstoffverabreichung
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας